| First Author | Lidón L | Year | 2021 |
| Journal | Int J Mol Sci | Volume | 22 |
| Issue | 10 | PubMed ID | 34065232 |
| Mgi Jnum | J:339739 | Mgi Id | MGI:6753462 |
| Doi | 10.3390/ijms22105370 | Citation | Lidon L, et al. (2021) Tau Exon 10 Inclusion by PrP(C) through Downregulating GSK3beta Activity. Int J Mol Sci 22(10) |
| abstractText | Tau protein is largely responsible for tauopathies, including Alzheimer's disease (AD), where it accumulates in the brain as insoluble aggregates. Tau mRNA is regulated by alternative splicing, and inclusion or exclusion of exon 10 gives rise to the 3R and 4R isoforms respectively, whose balance is physiologically regulated. In this sense, one of the several factors that regulate alternative splicing of tau is GSK3beta, whose activity is inhibited by the cellular prion protein (PrP(C)), which has different physiological functions in neuroprotection and neuronal differentiation. Moreover, a relationship between PrP(C) and tau expression levels has been reported during AD evolution. For this reason, in this study we aimed to analyze the role of PrP(C) and the implication of GSK3beta in the regulation of tau exon 10 alternative splicing. We used AD human samples and mouse models of PrP(C) ablation and tau overexpression. In addition, we used primary neuronal cultures to develop functional studies. Our results revealed a paralleled association between PrP(C) expression and tau 4R isoforms in all models analyzed. In this sense, reduction or ablation of PrP(C) levels induces an increase in tau 3R/4R balance. More relevantly, our data points to GSK3beta activity downstream from PrP(C) in this phenomenon. Our results indicate that PrP(C) plays a role in tau exon 10 inclusion through the inhibitory capacity of GSK3beta. |
